The majority of vaccine production in 2019 was in a handful of countries across Europe.
With all the challenges involved in both manufacturing and distributing the COVID-19 vaccines, it’s no surprise there are already some problems.
As countries scramble to get their own populations vaccinated first, many have made deals with manufacturers to pre-purchase large amounts of jabs, leading to the richest nations being the first to secure the majority of global vaccines.
‘Vaccine nationalism,’ as it has been named, creates a problem not just in terms of equal and fair access to the vaccines, but also when considering the global supply concerns that could arise when problems occur in the supply chain delaying vaccine production.
Scientists and global health organizations such as the World Health Organization have been calling for equitable access to the vaccines, and programs have been set up to encourage high-income economies to share the jabs.